^
    BIOMARKER:

    CD20 expression

    i
    Other names: CD20, MS4A1, Membrane Spanning 4-Domains A1, Membrane-Spanning 4-Domains, Subfamily A, Member 1, Leukocyte Surface Antigen Leu-16, B-Lymphocyte Antigen CD20, CD20 Antigen, Membrane-Spanning 4-Domains Subfamily A Member 1, B-Lymphocyte Cell-Surface Antigen B1, B-Lymphocyte Surface Antigen B1, CD20 Receptor, LEU-16, CVID5, MS4A2
    Entrez ID:
    494216
    Related biomarkers:
    Expression
    CD20 expression
    NHL
    rituximab-arrx
    Sensitive: A1 - Approval
    CD20 expression
    CLL
    rituximab-arrx
    Sensitive: A1 - Approval
    CD20 expression
    B Acute Lymphoblastic Leukemia
    rituximab
    Sensitive: C2 – Inclusion Criteria
    CD20 expression
    Childhood B Acute Lymphoblastic Leukemia
    rituximab + bortezomib
    Sensitive: C3 – Early Trials
    CD20 expression
    NHL
    REGN1979
    Resistant: C3 – Early Trials
    CD20 expression
    Lymphoma
    daratumumab + NKTR-255
    Sensitive: C3 – Early Trials
    CD20 expression
    Lymphoma
    NKTR-255 + Ritucad (rituximab biosimilar)
    Sensitive: D – Preclinical
    CD20 expression
    NHL
    lenalidomide + GEN3013
    Sensitive: D – Preclinical